UVSP Stock Analysis: Univest Pennsylvania | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.100m USD | 12M Return: 32.6% | US9152711001 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 8.71M
EPS Trend: 95.2%
Qual. Beats: -2
Rev. Trend: 93.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Univest Financial Corporation (NASDAQ: UVSP) is a bank holding company that operates Univest Bank and Trust Co., headquartered in Souderton, Pennsylvania. Founded in 1876, the company is a regional bank that has built a diversified business across three operating segments: Banking, Wealth Management, and Insurance. The corporate name was changed from Univest Corporation of Pennsylvania to Univest Financial Corporation in January 2019.
The Banking segment is the core of the franchise, providing deposit products, loan origination and servicing, mortgage banking, and equipment lease financing to individuals, businesses, municipalities, and non-profit organizations. As a regional bank serving its local Pennsylvania market, Univest relies on community-based deposit gathering and relationship lending rather than national or capital-markets activities, a business model typical of U.S. regional banks in the Financials sector.
The Wealth Management segment delivers investment advisory, financial planning, trust, and brokerage services to private families, individuals, and institutional clients such as municipal pension plans and retirement plans. The Insurance segment operates as a full-service insurance brokerage, offering commercial property and casualty, employee benefits, personal lines, and human resources consulting. Together, the wealth and insurance arms generate fee-based revenue that complements traditional net interest income from the banking business, a common diversification approach among community banks seeking more stable, non-cyclical income streams.
- Net interest margin moves with Fed rate path
- Wealth Management and Insurance fees diversify revenue base
- Commercial loan growth and credit quality in Pennsylvania market
| Net Income: 94.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.24 > 1.0 |
| NWC/Revenue: 8.70% < 20% (prev 197.0%; Δ -188.3% < -1%) |
| CFO/TA 0.01 > 3% & CFO 123.2m > Net Income 94.4m |
| Net Debt (214.0m) to EBITDA (122.6m): 1.75 < 3 |
| Current Ratio: 3.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.7m) vs 12m ago -4.20% < -2% |
| Gross Margin: 62.78% > 18% (prev 60.26%; Δ 2.52% > 0.5%) |
| Asset Turnover: 6.11% > 50% (prev 5.99%; Δ 0.12% > 0%) |
| Interest Coverage Ratio: 0.66 > 6 (EBIT TTM 117.8m / Interest Expense TTM 179.2m) |
| A: 0.01 (Total Current Assets 64.5m - Total Current Liabilities 18.8m) / Total Assets 8.61b |
| B: 0.07 (Retained Earnings 643.6m / Total Assets 8.61b) |
| C: 0.01 (EBIT TTM 117.8m / Avg Total Assets 8.59b) |
| D: 0.12 (Book Value of Equity 949.2m / Total Liabilities 7.66b) |
| Altman-Z'' = 0.50 = B |
As of November 20, 2026, the stock is trading at USD 39.04 with a total of 205,293 shares traded. Over the past week, the price has changed by -4.17%, over one month by -4.29%, over three months by -5.78% and over the past year by +32.55%.
Current recommended Stop Loss: 37.90 (which is 2.9% or 1.3 ATR below the current price).
Univest Pennsylvania has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold UVSP.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 45.2 | 15.7% |
P/E Trailing = 12.0955
P/E Forward = 13.0208
P/S = 3.3513
P/B = 1.1594
P/EG = 1.3027
Revenue TTM = 524.7m USD
EBIT TTM = 117.8m USD
EBITDA TTM = 122.6m USD
Long Term Debt = 224.1m USD (from longTermDebt, last quarter)
Short Term Debt = 186k USD (from shortTermDebt, last quarter)
Debt = 278.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 27.1m
Net Debt = 214.0m USD (calculated: Debt 278.5m - CCE 64.5m)
Enterprise Value = 1.31b USD (1.10b + Debt 278.5m - CCE 64.5m)
Interest Coverage Ratio = 0.66 (Ebit TTM 117.8m / Interest Expense TTM 179.2m)
EV/FCF = 11.41x (Enterprise Value 1.31b / FCF TTM 115.1m)
FCF Yield = 8.76% (FCF TTM 115.1m / Enterprise Value 1.31b)
FCF Margin = 21.94% (FCF TTM 115.1m / Revenue TTM 524.7m)
Net Margin = 17.98% (Net Income TTM 94.4m / Revenue TTM 524.7m)
Gross Margin = 62.78% ((Revenue TTM 524.7m - Cost of Revenue TTM 195.3m) / Revenue TTM)
Gross Margin QoQ = 59.95% (prev 64.71%)
Tobins Q-Ratio = 0.15 (Enterprise Value 1.31b / Total Assets 8.61b)
Interest Expense / Debt = 64.34% (Interest Expense 179.2m / Debt 278.5m)
Taxrate = 19.89% (23.4m / 117.8m)
NOPAT = 94.4m (EBIT 117.8m * (1 - 19.89%))
Current Ratio = 3.42 (Total Current Assets 64.5m / Total Current Liabilities 18.8m)
Debt / Equity = 0.29 (Debt 278.5m / totalStockholderEquity, last quarter 949.2m)
Debt / EBITDA = 1.75 (Net Debt 214.0m / EBITDA 122.6m)
Debt / FCF = 1.86 (Net Debt 214.0m / FCF TTM 115.1m)
Total Stockholder Equity = 949.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.10% (Net Income 94.4m / Total Assets 8.61b)
RoE = 9.94% (Net Income TTM 94.4m / Total Stockholder Equity 949.7m)
RoCE = 10.03% (EBIT 117.8m / Capital Employed (Equity 949.7m + L.T.Debt 224.1m))
RoIC = 1.10% (NOPAT 94.4m / Invested Capital 8.58b)
WACC = 5.99% (E(1.10b)/V(1.38b) * Re(7.51%) + (debt cost/tax rate unavailable))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.87 | Cagr: -2.47%
[DCF] Terminal Value 77.97% ; FCFF base≈106.8m ; Y1≈122.4m ; Y5≈180.2m
[DCF] Fair Price = 92.01 (EV 2.71b - Net Debt 214.0m = Equity 2.50b / Shares 27.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.22 | EPS CAGR: 16.77% | SUE: -3.26 | # QB: -2
Revenue Correlation: 93.67 | Revenue CAGR: 5.15% | SUE: 0.63 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.98 | Chg30d=-3.60% | Revisions=+50% | Analysts=3
EPS current Year (2026-12-31): EPS=3.62 | Chg30d=-4.99% | Revisions=+0% | GrowthEPS=+16.6% | GrowthRev=+8.3%
EPS next Year (2027-12-31): EPS=3.93 | Chg30d=-0.67% | Revisions=+50% | GrowthEPS=+8.7% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +67% (up=6, down=0)